• Explore /
  • Poster
  • / Plinabulin (Plin), a small molecule with anti-cancer activity and a novel mechanism of action (MoA) in docetaxel (Tax)-induced neutropenia: Phase (φ) 2 results from a head-to-head comparison with Pegfilgrastim (Peg).

Plinabulin (Plin), a small molecule with anti-cancer activity and a novel mechanism of action (MoA) in docetaxel (Tax)-induced neutropenia: Phase (φ) 2 results from a head-to-head comparison with Pegfilgrastim (Peg).

Abstract Poster

Authors

Douglas Blayney

Douglas W. Blayney

Stanford Cancer Institute, Stanford, CA

Douglas W. Blayney , Yuankai Shi , Igor Bondarenko , Qingyuan Zhang , Nadezhda Vitalievna Kovalenko , Jifeng Feng , Ihor Vynnychenko , Mikhail Valeryevich Kopp , Stephan Ogenstad , Lihua Du , Lan Huang , Ramon W. Mohanlal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Chemotherapy

Clinical Trial Registration Number

NCT03102606

Citation

J Clin Oncol 36, 2018 (suppl; abstr 2528)

DOI

10.1200/JCO.2018.36.15_suppl.2528

Abstract #

2528

Poster Bd #

354

Abstract Disclosures

Similar Posters

First Author: Douglas W. Blayney

First Author: Douglas W. Blayney

First Author: Yuankai Shi

Poster

2016 ASCO Annual Meeting

Variability in treatment choice among patients with breast, colorectal and lung cancer.

Variability in treatment choice among patients with breast, colorectal and lung cancer.

First Author: John Barron